Another study demonstrated that Tan IIA could reduce the levels of IL-6, TNF-α and IL-1β by markedly inhibiting the activation of NF-κB and the mitogen-activated protein kinases (MAPKs) pathways in a spinal cord injury model [25]. This evidence concerns the gene WNK2 and spinal cord injury.